Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New low · New Zealand stocks

Rua Bioscience Limited (RUA) closes at a 52-week low of NZD 0.025

Down 37.5% over 20 sessions. The previous lowest close was NZD 0.026 on 19 Nov 2025.

Published 6 October 2026 · Written from Tradzy's price and volume data

Close
NZD 0.025
On the day
−10.7%
Volume
1.6× average
vs 52-week high
−40.5%

Rua Bioscience Limited closing prices

NZD 0.0250NZD 0.0300NZD 0.0350NZD 0.0400Jun '26Jun '26Jul '26Aug '26Sep '26Oct '26NZD 0.0250

The last 90 closes up to 6 October 2026. The live chart is on the RUA page.

What happened

Rua Bioscience Limited (RUA) closed at NZD 0.025 on 6 October 2026, down 10.7% from NZD 0.028 the session before.

Over 5 sessions the price is down 16.7%, and over 20 sessions it is down 37.5%.

That close is below every close of the past year. The previous lowest was NZD 0.026 on 19 Nov 2025, and the new close is 3.8% under it.

Trading was heavy: volume was 1.6 times its average of the sessions before.

Across the 58 NZSE stocks we track, 42 closed higher and 11 closed lower that day, with a median change of +0.54%. RUA's change was −10.7%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeNZD 0.0280
CloseNZD 0.0250
Change on the day−10.71%
Change over 5 sessions−16.67%
Change over 20 sessions−37.50%
Volume125,687
Average volume, up to 20 sessions before80,271
Volume against that average1.6 times
Highest close in the past yearNZD 0.0420 (13 Jul 2026)
Lowest close in the past yearNZD 0.0260 (19 Nov 2025)

The full chart and history are on Rua Bioscience Limited (RUA). More from this market: NZSE news today.

More NZSE moves on 6 October 2026

Want a plan for RUA? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.